Oxymatrine CAS: 16837-52-8

CAS NO: 16837-52-8
Oxymatrine
Chemical Name: Ammothamnine
Molecular Formula: C15H24N2O2
Formula Weight: 264.36
CAS No.: 16837-52-8
Description Review
Description

Oxymatrine is a natural product derived from the roots of Sophora flavescens, a traditional Chinese medicinal herb. It has been used for centuries in Chinese medicine to treat a variety of ailments. Recently, oxymatrine has gained popularity as a dietary supplement due to its potential health benefits.

Chemical name Oxymatrine is also known as (4R-cis)-1,2-didehydro-4,5-epoxy-4-methyl-6-[1-(3,4,5-trimethoxyphenyl)ethyl]-3,3-piperidinediol.

Molecular formula The molecular formula of oxymatrine is C15H24N2O4.

Formula weight The formula weight of oxymatrine is 308.36 g/mol.

CAS No. Oxymatrine's CAS number is 16837-52-8.

Top Ten Keywords and Synonyms

  1. Oxymatrine side effects
  2. Oxymatrine benefits
  3. Oxymatrine dosage
  4. Oxymatrine cancer
  5. Oxymatrine liver
  6. Oxymatrine coronavirus
  7. Oxymatrine arthritis
  8. Sophora flavescens
  9. Chinese herbs
  10. Traditional medicine

Synonyms: Matrine oxide; 1H-Pyrrolizine, 1-methyl-3-[(9E)-3-phenylpropen-1-yl]decahydro-, (3S,4R)-rel-; 1H-Pyrrolizine, 1-methyl-3-[(9Z)-3-phenylpropen-1-yl]decahydro-, (3S,4R)-rel-; Dehydromatrine-N-oxide; Sophoflavescenol; Sophoroxides A

Health Benefits of Oxymatrine Oxymatrine has been shown to have several potential health benefits. One of the most promising areas of research is its use in treating liver disease. Studies have found that oxymatrine can help protect the liver from damage caused by toxins, viruses, and other harmful substances. This makes it a potential treatment option for conditions such as hepatitis, cirrhosis, and fatty liver disease.

Oxymatrine has also been studied for its potential anti-cancer properties. Some studies suggest that it may be able to inhibit the growth of certain types of cancer cells, including those found in breast, lung, and liver cancers. However, more research is needed to confirm these findings.

In addition to its potential liver-protective and anti-cancer effects, oxymatrine has also been studied for its anti-inflammatory properties. It may be useful in treating conditions such as rheumatoid arthritis, asthma, and inflammatory bowel disease.

Potential Effects of Oxymatrine Oxymatrine works by modulating the immune system and reducing inflammation. It is believed to do this by inhibiting the activity of certain enzymes and cytokines that play a role in inflammation and immune function.

Product Mechanism Oxymatrine's mechanism of action is not fully understood, but it is believed to work by modulating the immune system and reducing inflammation. It has been shown to inhibit the activity of certain enzymes and cytokines that play a role in these processes.

Safety Oxymatrine is generally considered safe when taken orally in recommended doses. However, some people may experience side effects such as nausea, vomiting, and diarrhea. It should not be taken by pregnant or breastfeeding women, as there is insufficient data on its safety in these populations. People with liver disease should also avoid taking oxymatrine, as it may worsen their condition.

Side Effects Oxymatrine can cause side effects such as nausea, vomiting, and diarrhea. In rare cases, it may also cause liver damage. If you experience any unusual symptoms after taking oxymatrine, you should stop using it and consult your healthcare provider.

Dosing Information The appropriate dose of oxymatrine depends on several factors, including age, health status, and the condition being treated. It is important to follow the dosing instructions provided on the product label or by your healthcare provider.

Conclusion Oxymatrine is a natural product derived from the roots of Sophora flavescens. It has several potential health benefits, including protecting the liver from damage, inhibiting the growth of certain types of cancer cells, and reducing inflammation. However, more research is needed to confirm these findings and determine the optimal dosing and safety profile of oxymatrine. As with any dietary supplement, it is important to speak with your healthcare provider before taking oxymatrine to ensure it is safe and appropriate for you

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code
Message Us